Jump Financial’s Phathom Pharmaceuticals PHAT Stock Holding History
Bought
Maintained
Sold
Other funds holding PHAT
6CM
Jump Financial's PHAT Position: Q3 2026 in Review
Jump Financial reduced its Phathom Pharmaceuticals (PHAT) stake by 85% in Q3 2026, selling an estimated $1.54M and leaving 28,900 shares worth $211K. The position accounts for ﹤0.01% of the portfolio, ranked #2101.
Jump Financial first reported a position in PHAT in Q4 2025 and has held it in 4 quarters since. The position peaked at $2.08M in Q2 2026. 161 funds tracked by Wall St. Rank hold PHAT as of Q3 2026.
- Jump Financial held 28,900 shares of Phathom Pharmaceuticals worth $211K as of Q3 2026.
- Jump Financial sold 162,966 Phathom Pharmaceuticals shares in Q3 2026, an estimated $1.54M.
- Phathom Pharmaceuticals made up ﹤0.01% of Jump Financial's portfolio in Q3 2026, its #2101 holding.
- Jump Financial first reported a position in Phathom Pharmaceuticals in Q4 2025 and has held it in 4 quarters since.
- Jump Financial's Phathom Pharmaceuticals position peaked at $2.08M in Q2 2026.
- 161 funds tracked by Wall St. Rank held Phathom Pharmaceuticals as of Q3 2026.
Based on Jump Financial's 13F filing for Q3 2026, filed 13 Nov 2026.